These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 14331)
21. Clinical evidence for multiple dopamine receptors in man. Meltzer HY Commun Psychopharmacol; 1979; 3(6):457-70. PubMed ID: 44694 [No Abstract] [Full Text] [Related]
22. Chronic neuroleptic therapy: tolerance and GABA systems. Lloyd KG; Shibuya M; Davidson L; Hornykiewicz O Adv Biochem Psychopharmacol; 1977; 16():409-15. PubMed ID: 18890 [No Abstract] [Full Text] [Related]
23. Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol. Asper H; Baggiolini M; Burki HR; Lauener H; Ruch W; Stille G Eur J Pharmacol; 1973 Jun; 22(3):287-94. PubMed ID: 4738903 [No Abstract] [Full Text] [Related]
28. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies. Nemeroff CB; Luttinger D; Hernandez DE; Mailman RB; Mason GA; Davis SD; Widerlöv E; Frye GD; Kilts CA; Beaumont K; Breese GR; Prange AJ J Pharmacol Exp Ther; 1983 May; 225(2):337-45. PubMed ID: 6682440 [TBL] [Abstract][Full Text] [Related]
29. Behavioral and biochemical correlates after haloperidol and clozapine long-term treatment. Racagni G; Bruno F; Bugatti A; Parenti M; Apud JA; Santini V; Carenzi A; Groppetti A; Cattabeni F Adv Biochem Psychopharmacol; 1980; 24():45-51. PubMed ID: 7405672 [No Abstract] [Full Text] [Related]
30. [Relationship of the homovanillic acid content in the rat brain after the administration of a neuroleptic and the degree of dopamine receptor sensitivity to an agonist]. Zharkovskiĭ AM; Allikmets LKh; Otter MIa Biull Eksp Biol Med; 1979 Jun; 87(6):559-60. PubMed ID: 572714 [TBL] [Abstract][Full Text] [Related]
31. Pharmacological profile of AD-5423, a novel antipsychotic with both potent dopamine-D2 and serotonin-S2 antagonist properties. Oka M; Noda Y; Ochi Y; Furukawa K; Une T; Kurumiya S; Hino K; Karasawa T J Pharmacol Exp Ther; 1993 Jan; 264(1):158-65. PubMed ID: 8093723 [TBL] [Abstract][Full Text] [Related]
32. Bromperidol, a new butyrophenone neuroleptic: a review. Dubinsky B; McGuire JL; Niemegeers CJ; Janssen PA; Weintraub HS; McKenzie BE Psychopharmacology (Berl); 1982; 78(1):1-7. PubMed ID: 6128755 [TBL] [Abstract][Full Text] [Related]
33. Pharmacological and biochemical studies on a new potential neuroleptic, N-(1-benzyl-3-pyrrolidinyl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-08050). Usuda S; Sano K; Maeno H Arch Int Pharmacodyn Ther; 1979 Sep; 241(1):68-78. PubMed ID: 43118 [TBL] [Abstract][Full Text] [Related]
34. Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity. Chipkin RE; Iorio LC; Coffin VL; McQuade RD; Berger JG; Barnett A J Pharmacol Exp Ther; 1988 Dec; 247(3):1093-102. PubMed ID: 2905002 [TBL] [Abstract][Full Text] [Related]
35. Correlation between neuroleptic-induced suppression of stereotyped behaviour and HVA concentrations in rat brain. Rollema H; Westerink BH; Grol CJ J Pharm Pharmacol; 1976 Apr; 28(4):321-3. PubMed ID: 6728 [No Abstract] [Full Text] [Related]
37. [Effect of carbidine on the dopamine and serotonin receptors of the central nervous system]. Zharkovskiĭ AM; Klassen NE; Zharkovskiĭ TA Biull Eksp Biol Med; 1985 Jun; 99(6):700-2. PubMed ID: 2861866 [TBL] [Abstract][Full Text] [Related]
38. Ergoline derivative LEK-8829-induced turning behavior in rats with unilateral striatal ibotenic acid lesions: interaction with bromocriptine. Sprah L; Zivin M; Sket D J Pharmacol Exp Ther; 1999 Mar; 288(3):1093-100. PubMed ID: 10027846 [TBL] [Abstract][Full Text] [Related]
39. The action of neuroleptics in rats with altered catecholamine metabolism. I. The influence of MAO inhibitors on the behavioral actions of chlorpromazine, haloperidol, and thioridazine. Vetulani J Pol J Pharmacol Pharm; 1973; 25(1):41-52. PubMed ID: 4798098 [No Abstract] [Full Text] [Related]
40. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity. Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]